Abcam Founder Opposes Danaher Deal, Wants Board Gone

By Renee Hickman · September 14, 2023, 5:52 PM EDT

A founder and one of the largest investors in life sciences company Abcam said Thursday that he opposes the company's proposed acquisition by Danaher and would vote against it, calling for...

To view the full article, register now.

Try a seven day FREE Trial

Already a subscriber? Click here to login

Recent Articles By Renee

February 14, 2024
Adagio Medical Goes Public In $128M SPAC Merger
February 12, 2024
Assure Buys Danam Health To Form $150M Business
February 06, 2024
McDermott-Led 3 Boomerang Nabs $375M For Debut Fund
September 27, 2023
Avalyn Pharma Raises $175M In Series C Financing Round
August 29, 2023
US Chamber Backs Amgen In FTC's $27.8B Merger Challenge
August 18, 2023
4 Firms Guide SPAC Deal For $300M Pregnancy Care Co. Nuvo
August 14, 2023
Life Sciences Biz Paying Up To $200M For CBD Drugmaker
August 07, 2023
Estia Health Gives Thumbs Up To AU$838M PE Takeover Bid
July 28, 2023
Tivity Appeals Nutrisystem Merger Investor Class Cert, Again
July 17, 2023
FTC Moves To Block IQVIA Deal Over Health Ad Concerns